Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update.
作者信息
Genest Jacques, Frohlich Jiri, Fodor George, McPherson Ruth
机构信息
Royal Victoria Hospital, McGill University, Montréal, Que.
出版信息
CMAJ. 2003 Oct 28;169(9):921-4.
Abstract
摘要
相似文献
1
Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update.
CMAJ. 2003 Oct 28;169(9):921-4.
2
Clinical practice guidelines for the management of dyslipidemia.
Can J Cardiovasc Nurs. 2004;14(2):7-10.
3
[Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
Ital Heart J Suppl. 2004 Jun;5(6):436-44.
4
5
[Treatment for hypertension with metabolic disorders (DM etc)].
Nihon Rinsho. 2006 Aug;64 Suppl 6:513-9.
6
[Dyslipidemia, diabetes and cardiovascular disease].
Ugeskr Laeger. 2000 Aug 14;162(33):4367-70.
7
Cardiovascular risk factors in adolescents: relevance, detection, and intervention.
Adolesc Med. 2001 Feb;12(1):147-62.
8
For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
Pharmacoepidemiol Drug Saf. 2008 May;17(5):485-94. doi: 10.1002/pds.1589.
9
Assessment of firefighters' cardiovascular disease-related knowledge and behaviors.
J Am Diet Assoc. 2001 Jul;101(7):807-9. doi: 10.1016/S0002-8223(01)00200-0.
10
[Primary prevention of cardiovascular disease].
Dtsch Med Wochenschr. 2005 Jan 7;130(1-2):38-43. doi: 10.1055/s-2005-837373.
引用本文的文献
1
Triglyceride-glucose index: a novel assessment tool for all-cause mortality in critical stroke patients-a retrospective analysis of the eICU-CRD database.
Cardiovasc Diabetol. 2025 Jul 26;24(1):304. doi: 10.1186/s12933-025-02872-9.
2
Total cholesterol/high-density lipoprotein cholesterol-related indices as predictors of obstructive sleep apnea and cardiovascular mortality: A cross-sectional study.
Medicine (Baltimore). 2025 Jun 13;104(24):e42872. doi: 10.1097/MD.0000000000042872.
3
Association of the total cholesterol to high-density lipoprotein cholesterol ratio with all-cause mortality risk in the migraine population.
J Headache Pain. 2025 Jun 5;26(1):135. doi: 10.1186/s10194-025-02077-1.
4
Evaluating the performance of a novel anthropometric index: weight adjusted for waist-to-height ratio (W-WHR) - for predicting cardiometabolic risk among adults in Addis Ababa.
BMJ Open. 2024 Jan 12;14(1):e077646. doi: 10.1136/bmjopen-2023-077646.
5
The effect of total cholesterol/high-density lipoprotein cholesterol ratio on mortality risk in the general population.
Front Endocrinol (Lausanne). 2022 Dec 15;13:1012383. doi: 10.3389/fendo.2022.1012383. eCollection 2022.
6
Uric acid and cardiometabolic risk by gender in youth with type 1 diabetes.
Sci Rep. 2022 Jul 15;12(1):12153. doi: 10.1038/s41598-022-15484-0.
7
Association of cytochromes P450 3A4*22 and 3A5*3 genotypes and polymorphism with response to simvastatin in hypercholesterolemia patients.
PLoS One. 2022 Jul 15;17(7):e0260824. doi: 10.1371/journal.pone.0260824. eCollection 2022.
8
Association between dual smoking and dyslipidemia in South Korean adults.
PLoS One. 2022 Jul 8;17(7):e0270577. doi: 10.1371/journal.pone.0270577. eCollection 2022.
9
Real-World Effectiveness of Therapy With Rosuvastatin Combined With Fenofibric Acid in a Sample of Colombian Patients With Mixed Dyslipidemia.
J Prim Care Community Health. 2020 Jan-Dec;11:2150132720977733. doi: 10.1177/2150132720977733.
10
Acetylator Genotype-Dependent Dyslipidemia in Rats Congenic for -Acetyltransferase 2.
Toxicol Rep. 2020 Sep 28;7:1319-1330. doi: 10.1016/j.toxrep.2020.09.011. eCollection 2020.
本文引用的文献
1
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
Lancet. 2002 Jul 6;360(9326):7-22. doi: 10.1016/S0140-6736(02)09327-3.
2
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.
JAMA. 2001 Apr 4;285(13):1711-8. doi: 10.1001/jama.285.13.1711.
3
4
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology.
Circulation. 1999 Sep 28;100(13):1481-92. doi: 10.1161/01.cir.100.13.1481.
Zotero 插件